Summary
The present study concerns the effects of MDL 72222 (0.5 mg · kg−1, i.v.), a 5-hydroxytryptamine3 (5-HT3) receptor antagonist, and methiothepin (1.0 mg · kg−1, i.v.), an antagonist of both 5-HT2 and “5-HT1-like” receptors, on the responses to local infusions of 5-HT (2.0 μg · kg−1 · min−1) on the total common carotid artery blood flow and its complete distribution in anaesthetized pigs. As reported earlier, more than 80% of the carotid blood bypassed the capillary circulation via cranial arteriovenous anastomoses, while approximately 15% and 2% was distributed to the extracerebral structures and brain, respectively. The total carotid blood flow did not change or was moderately reduced by 5-HT, but the amine consistently caused a 85% reduction in arteriovenous anastomotic blood flow and a 5-fold increase in blood flow to the extracerebral tissues, mainly the skin and ears. The colour of the skin and ears changed to bright pink. Complete recovery from the effects of 5-HT was observed once the infusion was stopped. MDL 72222 and methiothepin did not themselves affect carotid haemodynamics. The responses to 5-HT were not modified by MDL 72222 except that the reduction of the total carotid blood flow by 5-HT was augmented. In contrast, methiothepin almost completely abolished both the reduction of arteriovenous anastomotic blood flow and the increase in tissue blood flow following 5-HT-infusion. The colour of the skin and ears also did not become pink. In conjunction with our earlier findings that the constriction of arteriovenous anastomoses and the dilatation of arterioles caused by 5-HT within the carotid territory of the pig are not attenuated by 5-HT2 receptor antagonists (cyproheptadine, methysergide, ketanserin and WAL 1307), and are mimicked by agonists at “5-HT1-like” receptors (5-carboxamidotryptamine and BEA 1654), our results clearly establish that these responses are mediated by “5-HT1-like” receptors.
Similar content being viewed by others
References
Apperley E, Humphrey PPA, Levy GP (1976) Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. Br J Pharmacol 58:211–221
Apperley E, Feniuk W, Humphrey PPA, Levy GP (1980) Evidence for two types of excitatory receptors for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol 68:215–224
Black JL, French RJ, Mylecharane EJ (1981) Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries. Br J Pharmacol 74:619–626
Blackshear JL, Orlandi C, Garnic JD, Hollenberg NK (1985) Differential large and small vessel responses to serotonin in the dog hind limb in vivo: role of the 5-HT2 receptor. J Cardiovasc Pharmacol 7:42–49
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson B, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (in press)
Charlton KG, Bond RA, Clarke DE (1986) An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 332:8–15
Clancy BM, Maayani S (1985) 5-Hydroxytryptamine receptor in isolated rabbit aorta: Characterization with tryptamine analogues. J Pharmacol Exp Ther 233:761–769
Cohen ML, Mason N, Wiley KS, Fuller RW (1983) Further evidence that vascular serotonin receptors are of the 5-HT2-type. Biochem Pharmacol 32:567–570
Dobbins DE, Adamski SW, Lokhandwala MF, Grega GJ (1983) Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs. Circ Res 53:473–481
Duncker DJ, Heiligers J, Mylecharane EJ, Saxena PR, Verdouw PD (1986) Nimoclipine-induced changes in the distribution of carotid blood flow and cardiac output in the pentobarbital-anaesthetized pig. Br J Pharmacol (In press)
Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116–124
Feniuk W, Humphrey PPA, Watts AD (1981) Further characterization of pre- and post-junctional receptors for 5-hydroxytryptamine in isolated vasculature. Br J Pharmacol 73:191 P-192 P
Feniuk W, Humphrey PPA, Watts AD (1984) 5-Carboxamide tryptamine — a potent agonist at 5-hydroxytryptamine receptors mediating relaxation. Br J Pharmacol 82:209 P
Feniuk W, Humphrey PPA, Perren MK, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704
Fozard JR (1984) MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36–44
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Maricq HR (1972) Local effects of serotonin on blood vessels of human skin. Microvasc Res 4:258–263
McLennan PL, Taylor DA (1984) Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation. Eur J Pharmacol 104:313–318
Müller-Schweinitzer E, Engel G (1983) Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 324:287–292
Müller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild O (eds) Ergot alkaloids and related compounds, Handbook of experimental pharmacology, vol 49. Springer, Berlin Heidelberg New York, pp 87–332
Mylecharane EJ, Misbach J, Duckworth JW, Lance JW (1978) Effects of methysergide, pizotifen and ergotamine in the monkey cranial circulation. Eur J Pharmacol 48:1–9
Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in the rat brain. J Neurochem 36:220–226
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687–699
Peroutka SJ, Noguchi M, Tolner DJ, Allen GS (1983) Serotonin-induced contraction of canine basilar artery: mediation by 5-HT1 receptors. Brain Res 259:327–330
Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131
Saxena PR (1972) The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: Possible pharmacological implications to their antimigraine action. Headache 12:44–54
Saxena PR (1974) Selective vasoconstriction in carotid vascular bed, by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol 27:99–105
Saxena PR (1978) Arteriovenous shunting and migraine. Res Clin Stud Headache 6:89–102
Saxena PR, de Vlaam-Schluter GM (1974) Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine — Studies in an experimental model for migraine. Headache 13:142–163
Saxena PR, Lawang A (1985) A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn 277:235–252
Saxena PR, Verdouw PD (1982) Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous blood flow. J Physiol (Lond) 332:501–520
Saxena PR, Verdouw PD (1984) Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol 82:817–826
Saxena PR, Verdouw PD (1985a) 5-Carboxamide tryptamine, a compound with high affinity for 5-HT1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol 84:533–544
Saxena PR, Verdouw PD (1985b) Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflügers Arch 403:128–135
Saxena PR, Schamhardt HC, Forsyth RP, Loeve J (1980) Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variable in different experimental circumstances. Comput Progr Biomed 12:63–84
Saxena PR, Heiligers J, Mylecharane EJ, Tio R (1984a) Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M-and 5-HT2-type. J Autonom Pharmacol 5:101–107
Saxena PR, Mylecharane EJ, Heiligers J (1985b) Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 330:121–129
Saxena PR, van Houwelingen P, Bonta IL (1971) The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol 13:295–305
Spira PJ, Mylecharane EJ, Lance JW (1976) The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey. Res Clin Stud Headache 4:37–75
Steel RGD, Torrie JH (1980) Principles and procedures of statistics, a biomedical approach, 2nd edn. McGraw-Hill Kogakusha Ltd, Tokyo
Van Nueten JM, Janssen PAJ, van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217–230
Verdouw PD, Duncker DJ, Saxena PR (1984a) Poor vasoconstrictor response to adrenergic stimulation in the arteriovenous anastomoses present in the carotid vascular bed of young Yorkshire pigs. Arch Int Pharmacodyn 272:56–70
Verdouw PD, Jennewein HM, Heiligers J, Duncker DJ, Saxena PR (1984b) Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and WAL 1307. Eur J Pharmacol 102:499–509
Verdouw PD, Jennewein HM, Mierau J, Saxena PR (1985) N-(3-acetylaminophenyl) piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur J Pharmacol 107:337–346
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saxena, P.R., Duncker, D.J., Bom, A.H. et al. Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: Evidence for the presence of “5-hydroxytryptamine1-like” receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 198–204 (1986). https://doi.org/10.1007/BF00512930
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00512930